Did you know that the total annual direct healthcare costs for autoimmune conditions are nearly double that of cancer treatments? Find out how new treatment developments could help.
In a decision reached through the joint FDA/CMS Parallel Review process, CMS has granted national Medicare coverage to next-generation sequencing tests approved or cleared by the FDA as companion diagnostics for cancer therapies. This is clearly a win for Medicare beneficiaries and some NGS test providers—but is it also good news for MCOs?
Piedmont inherited multiple after hours answering service vendors with varying service levels and costs. Attend a webinar on 6/20 at 2 pm ET to learn how they standardized communication and improved service levels. Register >
ADVERTISEMENT
This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.
This email was sent by: %%Member_Busname%% %%Member_Addr%%
%%Member_City%%, %%Member_State%%, %%Member_PostalCode%%, %%Member_Country%%